• HotStart Universal 2X Green qPCR Master Mix in Gene Expressi

  2026-04-27

  Unlock precise, reproducible real-time PCR gene expression analysis using the HotStart Universal 2X Green qPCR Master Mix. This advanced dye-based master mix from APExBIO elevates specificity and reliability, streamlining quantification even in challenging oxidative stress and aging research models.

• RNA Pol II Inhibition Triggers Apoptosis via Non-Transcripti

  2026-04-27

  Harper et al. (2025) reveal that inhibition of RNA polymerase II (RNA Pol II) induces programmed cell death through a regulated apoptotic mechanism that is independent of transcriptional shutdown. This finding redefines how cell death is initiated by transcriptional inhibitors and highlights new mechanistic targets for research on apoptosis and cellular stress responses.

• iMSC-Exosome Modulation of Macrophage-NP Interaction in Disc

  2026-04-26

  This study reveals how exosomes from human iPSC-derived MSCs disrupt the cycle of senescence and inflammation between nucleus pulposus cells and macrophages in intervertebral disc degeneration models. By delivering miR-100-5p, these exosomes reprogram macrophage metabolism, offering a mechanistically supported therapeutic avenue for discogenic disease.

• YTHDF1 Phase Separation in SSC Fate: The IkB-NF-kB-CCND1 Axi

  2026-04-25

  Fang et al. reveal that YTHDF1-driven liquid-liquid phase separation (LLPS) is essential for the direct transdifferentiation of spermatogonial stem cells (SSCs) into neural stem cell-like cells. By modulating the translation of IkBa/b mRNAs, YTHDF1 LLPS activates the IkB-NF-kB-CCND1 signaling cascade, highlighting a pivotal mechanism in cell fate determination with implications for regenerative and translational medicine.

• Mianserin HCl–DM-β-CD Complexation and Its Impact on Cytotox

  2026-04-24

  This study systematically investigates the interaction between Mianserin HCl and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD), focusing on complex formation and its effects on cytotoxicity in mammalian cells. The findings reveal that, unlike prior β-cyclodextrin complexes, DM-β-CD does not mitigate Mianserin HCl's cytotoxicity, underscoring the importance of cyclodextrin selection for optimizing antidepressant research compound safety profiles.

• Live-Dead Cell Staining Kit: Practical Guide for Viability A

  2026-04-24

  The Live-Dead Cell Staining Kit enables accurate discrimination between viable and non-viable cells using Calcein-AM and Propidium Iodide dual staining, supporting fluorescence-based cell viability assays in research settings. It is best suited for applications such as flow cytometry and fluorescence microscopy, but is not intended for diagnostic or clinical use. Researchers should follow recommended storage and handling protocols to ensure assay reliability.

• KX2-391 dihydrochloride: Applied Protocols in Oncology & Neu

  2026-04-23

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) stands out as a dual-mechanism inhibitor, accelerating translational research in oncology, virology, and neurotoxin studies. This article delivers actionable protocols, troubleshooting advice, and evidence-based insights to empower bench scientists deploying KX2-391 dihydrochloride in complex cell-based and in vivo workflows.

• Comprehensive Metabolic Profiling of Tiamulin in Farm Animal

  2026-04-23

  This study provides a detailed, comparative analysis of Tiamulin metabolism across multiple farm animal species using UHPLC-Q/TOF. By mapping 26 unique metabolites and characterizing key metabolic pathways, the work refines our understanding of residue markers relevant for veterinary safety and regulatory compliance.

• Canagliflozin (hemihydrate) in Cell Viability and Glucose Re

  2026-04-22

  This article addresses key laboratory challenges in cell viability and glucose metabolism research, offering scenario-driven, evidence-based guidance on deploying Canagliflozin (hemihydrate) (SKU C6434). Emphasizing data reliability, assay compatibility, and supplier confidence, it provides actionable recommendations for biomedical researchers seeking robust and reproducible results.

• Catalpol Workflows: Applied Protocols & Troubleshooting in T

  2026-04-22

  Catalpol, a natural iridoid glycoside, offers robust multi-pathway modulation for neuroprotection, osteoporosis, ischemic stroke, liver fibrosis, and depression models. This article delivers actionable protocols, troubleshooting strategies, and cutting-edge guidance for maximizing Catalpol’s translational impact across diverse experimental systems.

• Epoxomicin in Antiviral Immunity: Beyond Proteasome Inhibiti

  2026-04-21

  Explore the role of Epoxomicin as a proteasome inhibitor in dissecting ubiquitin-proteasome-mediated antiviral immunity. This article uniquely bridges mechanistic insights and reference-driven evidence for advanced research applications.

• ARCA EGFP mRNA: Mechanistic Insights for Precision Transfect

  2026-04-21

  Explore how ARCA EGFP mRNA, a direct-detection enhanced green fluorescent protein mRNA, advances the science of transfection efficiency assays in mammalian cells. This article uniquely dissects its molecular mechanisms and connects them to next-generation mRNA delivery strategies.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-04-20

  Mdivi-1 enables precise modulation of mitochondrial fission, making it indispensable for advanced apoptosis assays and neuroprotection models. This article unpacks optimized workflows, troubleshooting strategies, and translational insights from the latest SP1/ADAM10/DRP1 axis research.

• Targeting BCL-XL and MCL-1 in Glioblastoma: Apoptotic Sensit

  2026-04-20

  This study demonstrates that glioblastoma (GBM) cells exhibit elevated anti-apoptotic BCL-XL and MCL-1 expression, making them highly sensitive to BH3-mimetic inhibitors. Sequential targeting of these proteins induces robust tumor cell apoptosis in preclinical models, revealing a promising strategy to overcome GBM's resistance to conventional therapies.

• Fingolimod (FTY720): Precision Immune Engineering in Solid T

  2026-04-19

  Discover how Fingolimod (FTY720) enables advanced immune cell trafficking and neuroprotection in solid tumor research. This article uniquely bridges S1P receptor modulation with next-generation in vivo immune engineering, offering fresh insights beyond classical multiple sclerosis workflows.

16355 records 1/1091 page Next 12345 下5页 Last page